Drugs and children: taking care of the victims

D A DeSylvia1, C D Klug

  • 1Vision Care, Wollaston, PA 02170.

Journal of the American Optometric Association
|January 1, 1992
PubMed

Insights

Cocaine exposure in infants, both prenatal and environmental, increases risks for developmental and vision problems. Healthcare providers must recognize and address the needs of these vulnerable children.

Area of Science:

  • Pediatric Health
  • Developmental Toxicology
  • Ophthalmology

Background:

  • Prenatal cocaine exposure affects fetal development, leading to potential health issues.
  • Environmental cocaine exposure poses risks to older infants and children.
  • A significant percentage of infants in urban settings show evidence of prenatal cocaine exposure.

Purpose of the Study:

  • To highlight the risks of developmental difficulties, particularly vision problems, in infants exposed to cocaine.
  • To raise awareness among healthcare providers about children at risk due to cocaine exposure.
  • To emphasize the need for sensitivity and appropriate care for these children.

Main Methods:

  • This study is based on existing data and clinical observations regarding cocaine-exposed infants and children.
  • Literature review on the effects of prenatal and environmental cocaine exposure on child development.
  • Analysis of estimated prevalence rates of cocaine exposure in urban hospital births.

Main Results:

  • Infants exposed to cocaine in utero face a heightened risk of developmental challenges, including visual impairments.
  • Over 10% of infants born in city hospitals are estimated to have prenatal cocaine exposure.
  • Children exposed to environmental cocaine also exhibit increased health risks.

Conclusions:

  • Healthcare providers must be vigilant in identifying and managing developmental issues in children with a history of cocaine exposure.
  • Early recognition and intervention are crucial for mitigating the long-term effects of cocaine exposure.
  • Increased awareness and sensitivity are necessary to support the health and development of at-risk children.

Related Concept Videos

Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...